Literature DB >> 33673073

Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation.

Jian Zhang1, Catherine A Powell1, Matthew K Kay1, Ravi Sonkar1, Sunitha Meruvu1, Mahua Choudhury1.   

Abstract

Western diets contribute to metabolic diseases. However, the effects of various diets and epigenetic mechanisms are mostly unknown. Here, six week-old C57BL/6J male and female mice were fed with a low-fat diet (LFD), high-fat diet (HFD), and high-fat high-fructose diet (HFD-HF) for 20 weeks. We determined that HFD-HF or HFD mice experienced significant metabolic dysregulation compared to the LFD. HFD-HF and HFD-fed male mice showed significantly increased body weight, liver size, and fasting glucose levels with downregulated PPARγ, SCD1, and FAS protein expression. In contrast, female mice were less affected by HFD and HFD-HF. As miR-27b contains a seed sequence in PPARγ, it was discovered that these changes are accompanied by male-specific upregulation of miR-27b-5p, which is even more pronounced in the HFD-HF group (p < 0.01 vs. LFD) compared to the HFD group (p < 0.05 vs. LFD). Other miR-27 subtypes were increased but not significantly. HFD-HF showed insignificant changes in fibrosis markers when compared to LFD. Interestingly, fat ballooning in hepatocytes was increased in HFD-fed mice compared to HFD-HF fed mice, however, the HFD-HF liver showed an increase in the number of small cells. Here, we concluded that chronic Western diet-composition administered for 20 weeks may surpass the non-alcoholic fatty liver (NAFL) stage but may be at an intermediate stage between fatty liver and fibrosis via miR-27b-5p-induced PPARγ downregulation.

Entities:  

Keywords:  PPARγ; diabetes; fibrosis progression; high-fat high-fructose diet; non-alcoholic fatty liver disease; noncoding RNA; obesity

Mesh:

Substances:

Year:  2021        PMID: 33673073      PMCID: PMC7917964          DOI: 10.3390/ijms22041822

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  62 in total

Review 1.  The metabolic syndrome: a call to action.

Authors:  Antonio M Gotto; George L Blackburn; George E Dailey; Alan J Garber; Scott M Grundy; Burton E Sobel; Matthew R Weir
Journal:  Coron Artery Dis       Date:  2006-02       Impact factor: 1.439

2.  Analysis of the role of hepatic PPARγ expression during mouse liver regeneration.

Authors:  Vered Gazit; Jiansheng Huang; Alexander Weymann; David A Rudnick
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

Review 3.  Therapies in non-alcoholic steatohepatitis (NASH).

Authors:  Abdul M Oseini; Arun J Sanyal
Journal:  Liver Int       Date:  2017-01       Impact factor: 5.828

4.  Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

Authors:  Jukka Westerbacka; Maria Kolak; Tuula Kiviluoto; Perttu Arkkila; Jukka Sirén; Anders Hamsten; Rachel M Fisher; Hannele Yki-Järvinen
Journal:  Diabetes       Date:  2007-08-17       Impact factor: 9.461

5.  Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Authors:  Sabine Thuy; Ruth Ladurner; Valentina Volynets; Silvia Wagner; Stefan Strahl; Alfred Königsrainer; Klaus-Peter Maier; Stephan C Bischoff; Ina Bergheim
Journal:  J Nutr       Date:  2008-08       Impact factor: 4.798

6.  Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome.

Authors:  Robert H Lustig; Kathleen Mulligan; Susan M Noworolski; Viva W Tai; Michael J Wen; Ayca Erkin-Cakmak; Alejandro Gugliucci; Jean-Marc Schwarz
Journal:  Obesity (Silver Spring)       Date:  2015-10-26       Impact factor: 5.002

Review 7.  Nuclear receptors in liver disease.

Authors:  Martin Wagner; Gernot Zollner; Michael Trauner
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

8.  Policy: NIH plans to enhance reproducibility.

Authors:  Francis S Collins; Lawrence A Tabak
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

Review 9.  Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome.

Authors:  Abalo Chango; Igor P Pogribny
Journal:  Nutrients       Date:  2015-04-14       Impact factor: 5.717

Review 10.  The molecular hallmarks of epigenetic control.

Authors:  C David Allis; Thomas Jenuwein
Journal:  Nat Rev Genet       Date:  2016-06-27       Impact factor: 53.242

View more
  4 in total

1.  SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.

Authors:  Helena Leal; João Cardoso; Patrícia Valério; Marta Quatorze; Vítor Carmona; Janete Cunha-Santos; Luís Pereira de Almeida; Cláudia Pereira; Cláudia Cavadas; Pedro Gomes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

Review 2.  The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD.

Authors:  Ting Hong; Yiyan Chen; Xiaoying Li; Yan Lu
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

3.  Enhanced silver nanoparticle-induced pulmonary inflammation in a metabolic syndrome mouse model and resolvin D1 treatment.

Authors:  Saeed Alqahtani; Li Xia; Jonathan H Shannahan
Journal:  Part Fibre Toxicol       Date:  2022-08-06       Impact factor: 9.112

4.  Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches.

Authors:  Elnaz Ghoreishi; Seyedeh Zahra Shahrokhi; Faranak Kazerouni; Ali Rahimipour
Journal:  BMC Endocr Disord       Date:  2022-08-17       Impact factor: 3.263

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.